Carolina Donat-Vargas1, Ingvar A Bergdahl2, Andreas Tornevi2, Maria Wennberg3, Johan Sommar2, Jani Koponen4, Hannu Kiviranta4, Agneta Åkesson5. 1. Institute of Environmental Medicine, Karolinska Institutet, Stockholm, Sweden. 2. Department of Public Health and Clinical Medicine, Occupational and Environmental Medicine, Umeå University, Umeå, Sweden. 3. Department of Public Health and Clinical Medicine, Nutritional Research, Umeå University, Umeå, Sweden. 4. Department for Health Security, Environmental Health Unit, National Institute for Health and Welfare, Kuopio, Finland. 5. Institute of Environmental Medicine, Karolinska Institutet, Stockholm, Sweden. Electronic address: Agneta.Akesson@ki.se.
Abstract
BACKGROUND: Perfluoroalkyl substances (PFAS) are persistent synthetic chemicals that may affect components of metabolic risk through the peroxisome proliferator-activated receptor but epidemiological data remain scarce and inconsistent. OBJECTIVE: To estimate associations between repeated measurements of the main PFAS in plasma and total cholesterol, triglycerides and hypertension among the control subjects from a population-based nested case-control study on diabetes type 2 in middle-aged women and men. METHODS: Participants (n = 187) were free of diabetes at both baseline and follow-up visits to the Västerbotten Intervention Programme, 10 years apart: during 1990 to 2003 (baseline) and 2001 to 2013 (follow-up). Participants left blood samples, completed questionnaires on diet and lifestyle factors, and underwent medical examinations, including measurement of blood pressure. PFAS and lipids were later determined in stored plasma samples. Associations for the repeated measurements were assessed using generalized estimating equations. RESULTS: Six PFAS exceeded the limit of quantitation. Repeated measures of PFAS in plasma, cardiometabolic risk factors and confounders, showed an average decrease of triglycerides from -0.16 mmol/l (95% confidence interval [CI]: -0.33, 0.02 for PFOA) to -0.26 mmol/l (95% CI: -0.50, -0.08 for PFOS), when comparing the highest tertile of PFAS plasma levels with the lowest. Associations based on average PFAS measurements and follow-up triglycerides revealed similar inverse associations, although attenuated. The estimates for cholesterol and hypertension were inconsistent and with few exception non-significant. CONCLUSIONS: This study found inverse associations between PFAS and triglycerides, but did not support any clear link with either cholesterol or hypertension.
BACKGROUND:Perfluoroalkyl substances (PFAS) are persistent synthetic chemicals that may affect components of metabolic risk through the peroxisome proliferator-activated receptor but epidemiological data remain scarce and inconsistent. OBJECTIVE: To estimate associations between repeated measurements of the main PFAS in plasma and total cholesterol, triglycerides and hypertension among the control subjects from a population-based nested case-control study on diabetes type 2 in middle-aged women and men. METHODS:Participants (n = 187) were free of diabetes at both baseline and follow-up visits to the Västerbotten Intervention Programme, 10 years apart: during 1990 to 2003 (baseline) and 2001 to 2013 (follow-up). Participants left blood samples, completed questionnaires on diet and lifestyle factors, and underwent medical examinations, including measurement of blood pressure. PFAS and lipids were later determined in stored plasma samples. Associations for the repeated measurements were assessed using generalized estimating equations. RESULTS: Six PFAS exceeded the limit of quantitation. Repeated measures of PFAS in plasma, cardiometabolic risk factors and confounders, showed an average decrease of triglycerides from -0.16 mmol/l (95% confidence interval [CI]: -0.33, 0.02 for PFOA) to -0.26 mmol/l (95% CI: -0.50, -0.08 for PFOS), when comparing the highest tertile of PFAS plasma levels with the lowest. Associations based on average PFAS measurements and follow-up triglycerides revealed similar inverse associations, although attenuated. The estimates for cholesterol and hypertension were inconsistent and with few exception non-significant. CONCLUSIONS: This study found inverse associations between PFAS and triglycerides, but did not support any clear link with either cholesterol or hypertension.
Authors: Pi-I D Lin; Andres Cardenas; Russ Hauser; Diane R Gold; Ken P Kleinman; Marie-France Hivert; Abby F Fleisch; Antonia M Calafat; Thomas F Webster; Edward S Horton; Emily Oken Journal: Environ Int Date: 2019-05-28 Impact factor: 9.621
Authors: Pengfei Guo; Tristan Furnary; Vasilis Vasiliou; Qi Yan; Kate Nyhan; Dean P Jones; Caroline H Johnson; Zeyan Liew Journal: Environ Int Date: 2022-02-26 Impact factor: 9.621
Authors: Ning Ding; Carrie A Karvonen-Gutierrez; Bhramar Mukherjee; Antonia M Calafat; Siobán D Harlow; Sung Kyun Park Journal: Hypertension Date: 2022-06-13 Impact factor: 9.897
Authors: Pi-I D Lin; Andres Cardenas; Russ Hauser; Diane R Gold; Ken P Kleinman; Marie-France Hivert; Antonia M Calafat; Thomas F Webster; Edward S Horton; Emily Oken Journal: Environ Int Date: 2020-02-20 Impact factor: 9.621
Authors: Gang Liu; Bo Zhang; Yang Hu; Jennifer Rood; Liming Liang; Lu Qi; George A Bray; Lilian DeJonge; Brent Coull; Philippe Grandjean; Jeremy D Furtado; Qi Sun Journal: Environ Health Date: 2020-01-13 Impact factor: 5.984
Authors: Maryam Zare Jeddi; Teresa Dalla Zuanna; Giulia Barbieri; Aline S C Fabricio; Francesca Daprà; Tony Fletcher; Francesca Russo; Gisella Pitter; Cristina Canova Journal: Int J Environ Res Public Health Date: 2021-01-29 Impact factor: 3.390
Authors: Michael C Petriello; M Abdul Mottaleb; Tara C Serio; Bharat Balyan; Matthew C Cave; Marian Pavuk; Linda S Birnbaum; Andrew J Morris Journal: Environ Int Date: 2021-11-08 Impact factor: 13.352
Authors: Susanna D Mitro; Sharon K Sagiv; Abby F Fleisch; Lindsay M Jaacks; Paige L Williams; Sheryl L Rifas-Shiman; Antonia M Calafat; Marie-France Hivert; Emily Oken; Tamarra M James-Todd Journal: J Clin Endocrinol Metab Date: 2020-09-01 Impact factor: 5.958